Barclays’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96K | Buy |
10,582
+3,949
| +60% | +$35.8K | ﹤0.01% | 3832 |
|
|
2025
Q1 | $64K | Sell |
6,633
-3,015
| -31% | -$29.1K | ﹤0.01% | 3831 |
|
|
2024
Q4 | $108K | Buy |
9,648
+1,088
| +13% | +$12.2K | ﹤0.01% | 3777 |
|
|
2024
Q3 | $123K | Buy |
8,560
+6,538
| +323% | +$93.9K | ﹤0.01% | 3688 |
|
|
2024
Q2 | $35K | Buy |
+2,022
| New | +$35K | ﹤0.01% | 3787 |
|
|
2022
Q2 | – | Sell |
-665
| Closed | -$13K | – | 4790 |
|
|
2022
Q1 | $13K | Buy |
+665
| New | +$13K | ﹤0.01% | 4432 |
|